共 376 条
[1]
Younossi ZM(2016)Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-84
[2]
Koenig AB(2011)Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008 Clin Gastroenterol Hepatol 9 524-530
[3]
Abdelatif D(2015)Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009 Hepatology 62 1723-1730
[4]
Fazel Y(2019)Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates Clin Gastroenterol Hepatol 17 748-755.e3
[5]
Henry L(2002)Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine Altern Med Rev 7 276-291
[6]
Wymer M(2014)Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes Hepatology 59 713-723
[7]
Younossi ZM(1996)Magnesium deficiency and glucose metabolism in rat adipocytes Metabolism 45 838-843
[8]
Stepanova M(1995)Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM Am J Physiol 269 E745-752
[9]
Afendy M(2017)Effect of magnesium supplementation on insulin resistance in humans: a systematic review Nutrition 38 54-60
[10]
Fang Y(2018)Effect of magnesium sulfate administration to improve insulin resistance in type 2 diabetes animal model: using the hyperinsulinemic-euglycemic clamp technique Fundam Clin Pharmacol 32 603-616